DISCOVER iCaReMe Global Registry

  • STATUS
    Recruiting
  • End date
    Dec 31, 2025
  • participants needed
    20000
  • sponsor
    AstraZeneca
Updated on 8 July 2021
Investigator
AstraZeneca Clinical Study Information Center
Primary Contact
Research Site (6.5 mi away) Contact
+128 other location
diabetes
heart failure

Summary

To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, chronic kidney disease and heart failure

Description

The registry intends to provide real world data on patient management and quality of care for patients with T2DM, heat failure and chronic kidney disease in clinical practice in many countries. To bridge this gap an observational voluntary registry is set up to capture real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Heart Failure and Chronic Kidney Disease. Multinational, observational registry utilizing a cloud-based eCRF, for prospective and retrospective data collection, accessible to investigators and Scientific Committee. This registry will be open to all physicians managing T2DM, HF or CKD across the world.

Details
Condition chronic renal insufficiency, NIDDM, Diabetes Mellitus, Chronic renal failure, Heart failure, Heart disease, Diabetes Mellitus, Type 2, Diabetes Prevention, Diabetes Mellitus Types I and II, Diabetes (Pediatric), Congestive Heart Failure, Diabetes Mellitus Type 2, chronic kidney disease, type 2 diabetes mellitus, chronic kidney disease (ckd), cardiac failure, type 2 diabetes, type ii diabetes, noninsulin-dependent diabetes mellitus, diabetes type 2, congestive heart disease
Clinical Study IdentifierNCT03549754
SponsorAstraZeneca
Last Modified on8 July 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Being 18 years or older
Having type 2 diabetes, chronic kidney disease or heart failure
Providing written informed consent to participate in the registry

Exclusion Criteria

Having a life-threatening co-morbidity with life expectancy below 1 year
Participating in an interventional trial requiring informed consent
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note